Rep. Meadows Pursuing Solutions to Rising Prescription Drug Costs
December 06, 2019
December 06, 2019
WASHINGTON, Dec. 6 -- Rep. Mark Meadows, R-North Carolina, issued the following news release:
This week, Rep. Mark Meadows (R-NC) sent a letter to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) about barriers to market access for low-cost generic prescription medications and possible solutions to rising prescription drug costs.
Under President Trump, the FDA has expedited the approval process for a record-breaking number of generic and biosimi . . .
This week, Rep. Mark Meadows (R-NC) sent a letter to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) about barriers to market access for low-cost generic prescription medications and possible solutions to rising prescription drug costs.
Under President Trump, the FDA has expedited the approval process for a record-breaking number of generic and biosimi . . .